medicine | Page 6 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
August 09, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, AUGUST 09, 2026

medicine

medicine

A logo is pictured on the World Health Organisation (WHO) headquarters in Geneva, Switzerland, November 22, 2017. Reuters/Denis Balibouse

Access to HIV medicines severely impacted by Covid-19: WHO

73 countries have warned that they are at risk of stock-outs of antiretroviral (ARV) medicines amid the pandemic

File Photo

Bangladesh recommends controversial drugs for Covid-19 treatment

Counterfeit medicines and hand sanitisers seized in Bogura

Counterfeit medicines and hand sanitisers seized in Bogura

In this photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.AP Photo

Heartburn drug is being tested as a potenial coronavirus drug in New York hospitals

Photo:Collected

PM Hasina sends emergency medicines to Bhutan

Photo: Collected

Bangladesh achieves international recognition in quality testing for medicines

File Photo: Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. Reuters/Issei Kato

Beximco, Beacon pharma make Japanese Covid-19 drug

Online sales of pharmacies soar amid lockdown

Online sales of pharmacies soar amid lockdown

Representational image/Collected

DBL Pharma becomes second largest seller of popular muscle relaxant in US 

Photo: Mumit M

Production, marketing of food, medicine to continue

Photo: Rehman Asad/TBS

Laboratory medicine institute to rein in errant diagnostic centres

Photo: Mohammad Minhaz Uddin

Bangladesh to produce antivenom from 2022

NIPRO JMI Pharma holds scientific seminar

NIPRO JMI Pharma holds scientific seminar

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net